Masarwy, R.; Shilo, S.; Carmel Neiderman, N.N.; Kampel, L.; Horowitz, G.; Muhanna, N.; Mansour, J.
The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cancers 2023, 15, 2456.
https://doi.org/10.3390/cancers15092456
AMA Style
Masarwy R, Shilo S, Carmel Neiderman NN, Kampel L, Horowitz G, Muhanna N, Mansour J.
The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cancers. 2023; 15(9):2456.
https://doi.org/10.3390/cancers15092456
Chicago/Turabian Style
Masarwy, Razan, Shahaf Shilo, Narin Nard Carmel Neiderman, Liyona Kampel, Gilad Horowitz, Nidal Muhanna, and Jobran Mansour.
2023. "The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis" Cancers 15, no. 9: 2456.
https://doi.org/10.3390/cancers15092456
APA Style
Masarwy, R., Shilo, S., Carmel Neiderman, N. N., Kampel, L., Horowitz, G., Muhanna, N., & Mansour, J.
(2023). The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cancers, 15(9), 2456.
https://doi.org/10.3390/cancers15092456
